全文获取类型
收费全文 | 1293篇 |
免费 | 89篇 |
国内免费 | 1篇 |
专业分类
耳鼻咽喉 | 3篇 |
儿科学 | 54篇 |
妇产科学 | 15篇 |
基础医学 | 171篇 |
口腔科学 | 12篇 |
临床医学 | 96篇 |
内科学 | 423篇 |
皮肤病学 | 32篇 |
神经病学 | 140篇 |
特种医学 | 86篇 |
外科学 | 69篇 |
综合类 | 55篇 |
预防医学 | 94篇 |
眼科学 | 7篇 |
药学 | 91篇 |
中国医学 | 1篇 |
肿瘤学 | 34篇 |
出版年
2023年 | 3篇 |
2022年 | 4篇 |
2021年 | 16篇 |
2020年 | 10篇 |
2019年 | 6篇 |
2018年 | 11篇 |
2017年 | 14篇 |
2016年 | 26篇 |
2015年 | 30篇 |
2014年 | 38篇 |
2013年 | 46篇 |
2012年 | 47篇 |
2011年 | 76篇 |
2010年 | 58篇 |
2009年 | 49篇 |
2008年 | 81篇 |
2007年 | 64篇 |
2006年 | 90篇 |
2005年 | 77篇 |
2004年 | 59篇 |
2003年 | 63篇 |
2002年 | 59篇 |
2001年 | 34篇 |
2000年 | 33篇 |
1999年 | 33篇 |
1998年 | 32篇 |
1997年 | 45篇 |
1996年 | 31篇 |
1995年 | 22篇 |
1994年 | 27篇 |
1993年 | 21篇 |
1992年 | 15篇 |
1991年 | 9篇 |
1990年 | 13篇 |
1989年 | 31篇 |
1988年 | 15篇 |
1987年 | 11篇 |
1986年 | 17篇 |
1985年 | 14篇 |
1984年 | 6篇 |
1983年 | 4篇 |
1982年 | 3篇 |
1981年 | 4篇 |
1980年 | 6篇 |
1979年 | 2篇 |
1978年 | 4篇 |
1977年 | 9篇 |
1976年 | 5篇 |
1975年 | 5篇 |
1932年 | 1篇 |
排序方式: 共有1383条查询结果,搜索用时 15 毫秒
31.
Summary of findings from the evaluation of a pilot medically supervised safer injecting facility 总被引:1,自引:0,他引:1
下载免费PDF全文
![点击此处可从《Canadian Medical Association journal》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Evan Wood Mark W. Tyndall Julio S. Montaner Thomas Kerr 《Canadian Medical Association journal》2006,175(11):1399-1404
In many cities, infectious disease and overdose epidemics are occurring among illicit injection drug users (IDUs). To reduce these concerns, Vancouver opened a supervised safer injecting facility in September 2003. Within the facility, people inject pre-obtained illicit drugs under the supervision of medical staff. The program was granted a legal exemption by the Canadian government on the condition that a 3-year scientific evaluation of its impacts be conducted. In this review, we summarize the findings from evaluations in those 3 years, including characteristics of IDUs at the facility, public injection drug use and publicly discarded syringes, HIV risk behaviour, use of addiction treatment services and other community resources, and drug-related crime rates. Vancouver's safer injecting facility has been associated with an array of community and public health benefits without evidence of adverse impacts. These findings should be useful to other cities considering supervised injecting facilities and to governments considering regulating their use. 相似文献
32.
33.
34.
Mar Hernández-Guillamon Laura Ortega Cristina Merino-Zamorano Mireia Campos-Martorell Anna Rosell Joan Montaner 《Journal of neural transmission (Vienna, Austria : 1996)》2014,121(2):113-117
Most of neuroprotective strategies in stroke have failed to move from bench to bedside. One explanation might be the use of excessive uniform and smooth experimental models. Therefore, we have employed a more stringent in vitro model based on cultured brain slices from adult mice submitted to OGD. Using this acute model, we have confirmed that mild hypothermia protects against OGD-induced cell death when cooling the tissue during and after OGD, but not when hypothermia is induced only during reoxygenation. 相似文献
35.
Sonia Gutiérrez Silvia Guillemi Natalie Jahnke Valentina Montessori P Richard Harrigan Julio S G Montaner 《Clinical infectious diseases》2008,46(3):e28-e30
We summarize the clinical history and laboratory results following the introduction of tenofovir among 6 patients coinfected with human immunodeficiency virus (HIV) and hepatitis B virus (HBV) who presented with severe liver disease while receiving lamivudine-based highly active antiretroviral therapy. In all cases, the introduction of tenofovir led to a sustained undetectable HBV and HIV loads, with marked clinical and laboratory improvement in liver function. We provide supporting evidence for the role of tenofovir in the management of advanced HBV infection in HIV-positive patients after the development of lamivudine resistance. 相似文献
36.
Yamashita T; Wu N; Kupfer G; Corless C; Joenje H; Grompe M; D'Andrea AD 《Blood》1996,87(10):4424-4432
Fanconi anemia (FA) is an autosomal recessive disease characterized by congenital anomalies, aplastic anemia, and cancer susceptibility. Mutations within the FA complementation group C (FAC) gene account for approximately 14% of diagnosed FA cases. Two mutations, one in exon 1 (delG322) and one in exon 4 (IVS4 + 4 A to T), account for 90% of known FAC mutations. The delG322 mutation results in a mild FA phenotype, while the IVS4 + 4 A to T mutation results in severe FA phenotype. To determine the molecular basis for this clinical variability, we analyzed patient-derived cell lines for the expression of characteristic mutant FAC polypeptides. All cell lines with the delG322 mutation expressed a 50-kD FAC polypeptides, FRP-50 (FAC-related protein), shown to be an amino terminal truncated isoform of FAC reinitiated at methionine 55. All cell lines with the IVS4 + 4 A to T mutation lacked FRP-50. Overexpression of a cDNA encoding FRP-50 in an FA(C) cell line resulted in partial correction of mitomycin C sensitivity. In conclusion, expression of an amino terminal truncated FAC protein accounts, at least in part, for the clinical heterogeneity among FA(C) patients. 相似文献
37.
38.
39.
Isolation of drug-resistant variants of HIV-1 from patients on long-term zidovudine therapy. Canadian Zidovudine Multi-Centre Study Group 总被引:26,自引:0,他引:26
R Rooke M Tremblay H Soudeyns L DeStephano X J Yao M Fanning J S Montaner M O'Shaughnessy K Gelmon C Tsoukas 《AIDS (London, England)》1989,3(7):411-415
We determined whether drug-resistant variants of HIV-1 could be isolated from the peripheral blood mononuclear cells of 20 individuals with HIV infection (Centers for Disease Control groups II and III) on long-term zidovudine (AZT) therapy. Toward this end, zidovudine (10 microM) has been included in the tissue culture medium used to isolate HIV-1. Under these circumstances, virus with a zidovudine-resistant phenotype was successfully obtained in five out of 20 cases. This property of drug resistance appeared to be stable, and did not disappear upon extended replication of such virus in the absence of drug pressure. Drug-resistant virus could also be isolated from these subjects on subsequent occasions, but was not present in samples obtained prior to therapy. Replication of these zidovudine-resistant isolates in tissue culture was inhibited by each of four other nucleoside analogues. Thus, other drugs may be useful in controlling selective zidovudine-resistant variants of HIV-1. 相似文献
40.
Castillo Laita JA De Benito Fernández J Escribano Montaner A Fernández Benítez M García de la Rubia S Garde Garde J García-Marcos L González Díaz C Ibero Iborra M Navarro Merino M Pardos Martínez C Pellegrini Belinchon J Sánchez Jiménez J Sanz Ortega J Villa Asensi JR 《Allergologia et immunopathologia》2008,36(1):31-52